Extracorporeal removal of lipids by dextran sulfate cellulose adsorption

Artificial Organs

Volumn 20, Issue 4, 1996, Pages 332-335

  Olbricht, Christoph J ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Dextran sulfate; Familial hypercholesterolemia; Indications; Low density lipoprotein apheresis

Indexed keywords

CELLULOSE; CHOLESTEROL; DEXTRAN; DISEASES; LIPOPROTEINS; PATIENT TREATMENT; SULFUR COMPOUNDS;

CORONARY HEART DISEASE; DEXTRAN SULPHATE; FAMILIAL HYPERCHOLESTEROLEMIA; HYPERCHOLESTEROLEMIA; INDICATION; LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEINS; LOW-DENSITY LIPOPROTEIN APHERESIS; SIDE EFFECT; SULFATE ADSORPTION;

ADSORPTION;

CELLULOSE; DEXTRAN SULFATE; LIPID;

APHERESIS; ARTICLE; CORONARY ARTERY DISEASE; EXTRACORPOREAL CIRCULATION; HUMAN; HYPERCHOLESTEROLEMIA; PRIORITY JOURNAL;

EID: 0029973872     PISSN: 0160564X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1594.1996.tb04454.x     Document Type: Article

References (32)

1. Assmann G, Lewis B, Mancini M. The reconition and management of hyperlipidaemia in adults: a policy statement of the European Atherosclerosis Society. Eur Heart J 1988;9: 571-600.
2. Goldstein JL, Brown MS. Familial hypercholesterolemia. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic basis of inherited disease. 6th ed. New York: McGraw-Hill, 1989:672-712.
3. Hoeg JM, Brewer HB. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors in the treatment of hypercholesterolemia. JAMA 1987;258:3532-6.
4. Yokoyama S, Hayashi R, Kikkawa T, Tani N, Takada S, Hatanaka K, Yamamoto A. Specific sorbent of apolipoprotein B-containing lipoproteins for plasmapheresis. Characterization and experimental use in hypercholesterolemic rabbits. Arteriosclerosis 1984;4:276-82.
5. Mabuchi H, Michishita I, Takeda M, Fujita H, Koizumi J, Takeda R, Takada S, Oonishi M. A new low density lipoprotein apheresis system using two dextran sulfate cellulose columns in an automated column regenerating unit (LDL continuous apheresis). Atherosclerosis 1987;68:19-25.
6. Yokoyama S, Hayashi R, Satani M, Yamamoto A. Selective removal of low density lipoprotein by plasmapheresis in familial hypercholesterolemia. Arteriosclerosis 1985;5:613-22.
7. Homma Y, Mikami Y, Tamachi H, Nakaya N, Nakamura H, Goto Y. Comparison of selectivity of LDL removal by double filtration and dextran-sulfate cellulose column plasmapheresis and changes of subfractionated plasma lipoproteins after plasmapheresis in heterozygous familial hypercholesterolemia. Metabolism 1987;36:419-25.
8. Franceschini G, Busnach G, Vaccarino V, Calabresi L, Gianfranceschi G, Sirtori CR. Apheretic treatment of severe familial hypercholesterolemia: comparison of dextran sulfate cellulose and double membrane filtration methods for low density lipoprotein removal. Atherosclerosis 1988;73: 197-202.
9. Yamamoto A, Yokoyoma S, Satani M, Kikkawa T, Kishino B, eds. Evaluation of selective LDL removal in the treatment of familial hypercholesterolemia: double membrane filtration and adsorption. New York: Alan R. Liss, 1988: 357-466. (Widhalm K, Naito HK, eds. Recent aspects of diagnosis and treatment of lipoprotein disorders: impact on prevention of atherosclerostic diseases).
10. Yamamoto A, Yokoyoma S, Satani M, Kikkawa T, Kishino B, eds. Evaluation of selective LDL removal in the treatment of familial hypercholesterolemia: double membrane filtration and adsorption. New York: Alan R. Liss, 1988: 357-466. (Widhalm K, Naito HK, eds. Recent aspects of diagnosis and treatment of lipoprotein disorders: impact on prevention of atherosclerostic diseases).
11. Schulzeck P, Olbricht CJ, Koch KM. Long-term experience with extracorporeal low-density lipoprotein cholesterol removal by dextran sulfate cellulose adsorption. Clin Invest 1992;70:99-104.
12. Tait GW, Packard CJ, Shepherd J, Hutton I, Lorimer RA. Cholesterol reduction and regression of coronary atherosclerosis. In: Gordon BR, Gotto AM, Princeton NJ, eds. The treatment of severe hypercholesterolemia: can we impact disease course? Amsterdam: Excerpta Medica, 1992:83-9.
13. Tatami R, Inoue N, Itoh H, Kishino B, Koga N, Nakashima Y, Nishide T, Okamura K, Saito Y, Teramoto T, Yasugi T, Yamamoto A, Goto Y. Regression of coronary atheroscleosis by combined LDL apheresis and lipid lowering drug therapy in patients with familial hypercholesterolemia: a multicenter study. Atherosclerosis 1992;95:1-13.
14. Thompson GR, Maher VMG, Matthews S, Kitano Y, Neuwirth C, Shortt MB, Davies G, Rees A, Mir A, Prescott RJ, deFeyter P, Henderson A. Familial hypercholesterolaemia regression study: a randomised trial of low-density lipoprotein apheresis. Lancet 1995;345:811-6.
15. Nakajima T, Nakamura T, Funahashi T, Kanai H, Kurata Y, Matsuzawa Y, Tarui S. A novel system of LDL apheresis combining a centrifugal plasma separator with a specific LDL adsorption column. Atherosclerosis 1988;73:143-8.
16. Eriksson M, Berg B, Berglund L, Lantz B, Angelin B. Lipid lowering in severe familial hypercholesterolemia: efficacy and safety of a new regenerating system for selective apheresis of apolipoprotein B-containing lipoproteins. J Intern Med 1989;225:29-34.
17. Kojima S, Harada-Shiba M, Nomura S, Kimura G, Tsushima M, Kuramochi M, Yamamoto A, Omae T. Effect of nafamostat mesilate on bradykinine generation during low-density lipoprotein apheresis using a dextran sulfate cellulose column. Trans Am Soc Artif Intern Organs 1991;37: 644-8.
18. Yamamoto A, Kojima S, Shiba-Harada M, Kawaguchi A, Hatanaka K. Assessment of the biocompatibility and long-term effect of LDL apheresis by dextran sulfate-cellulose column. Artif Organs 1992;16:177-81.
19. Schaumann D, Olbricht CJ, Welp-Wichary M, Voss A, Schmidt H, Schulzeck P, Schulze M, Haubitz M, Koch KM. Extracorporeal removal of LDL cholesterol: prospective evaluation of effectivity, selectivity, and biocompatibility (abstract). J Am Soc Nephhrol 1992;3:392.
20. Grützmacher P, Landgraf H, Esser R, Okon J, Vlachojannis J, Ehrly AM, Schoeppe W. In vivo rheologic effects of lipid apheresis techniques: comparison of dextran sulfate LDL adsorption and heparin induced LDL precipitation. ASAIO Trans 1990;36:M327-M330.
21. Berger GM, Firth JC, Jacobs P, Wood L, Marais D, Horak A. Three different schedules of low-density lipoprotein apheresis compared with plasmapheresis in patients with homozygous familial hypercholesterolemia. Am J Med 1990; 88:94-100.
22. Kozin F, Cochran CG. The contact activation system of plasma: biochemistry and pathophysiology. In: Gallin JL, Goldstein IM, Snyderman R, eds. Inflammation: basic principles and clinical correlates. New York: Raven Press, 1988: 101-20.
23. Olbricht CJ, Schaumann D, Fischer D. Anaphylactoid reactions, LDL apheresis with dextran sulphate, and ACE inhibitors. Lancet 1992;340:908-9.
24. Yamamoto A. Regression of atherosclerosis in humans by lowering serum cholesterol. Atherosclerosis 1991;89:1-10.
25. Koga N, Iwata Y. Pathological and angiographic regression of coronary atherosclerosis by LDL-apheresis in a patient with familial hypercholesterolemia. Atherosclerosis 1991;90: 9-21.
26. Blankenhorn DH, Nessim SA, Johnson RL, Sanmarco ME, Azen SP, Cashin-Hemphill L. Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. JAMA 1987;257:3233-40.
27. Brown G, Albers JJ, Fisher LD, Schaefer SM, Lin JT, Kaplan C, Zhao XQ, Bisson BD, Fitzpatrick VF, Dodge HT. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apoprotein-B. N Engl J Med 1990;323:1289-98.
28. Aghishi T, Kitano Y, Suzuki T, Miura A, Murakami J, Minagawa H, Ban K. Improvement of peripheral circulation by low density lipoprotein adsorption. Trans Am Soc Artif Intern Organs 1989;35:349-51.
29. Rubba P, Iannuzzi A, Postiglione A, Scarpato N, Montefusco S, Gnasso A, Nappi G, Cortese C, Mancini M. Hemodynamic changes in the peripheral circulation after repeat low density lipoprotein apheresis in familial hypercholesterolemia. Circulation 1990;81:610-6.
30. Creager MA, Cooke JP, Mendelsohn ME, Gallagher SJ, Coleman SM, Loscalzo J, Dzau VJ. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest 1990;86:228-34.
31. Sakai S, Mune M, Iino Y, Ohtsubo O, Sugino N. Effect of LDL-apheresis in patients with drug-resistant nephrotic syndrome - multicenter cooperative study. Kidney Dial 1992; 33:321-8.
32. Muso E, Yashiro M, Sawanishi K. Effect of LDL-apheresis for steroid-resistant nephrotic syndromes (abstract). Nephrol Dial Transplant 1992;7:693.